Daiichi Sankyo Company, Limited (DSKYF)
USD 26.5
(0.0%)
USD 26.5
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 200.73 Billion JPY | 83.84% |
| 2023 | 109.18 Billion JPY | 63.04% |
| 2022 | 66.97 Billion JPY | -11.83% |
| 2021 | 75.95 Billion JPY | -41.15% |
| 2020 | 129.07 Billion JPY | 38.18% |
| 2019 | 93.4 Billion JPY | 54.95% |
| 2018 | 60.28 Billion JPY | 12.75% |
| 2017 | 53.46 Billion JPY | -35.02% |
| 2016 | 82.28 Billion JPY | -74.46% |
| 2015 | 322.11 Billion JPY | 428.56% |
| 2014 | 60.94 Billion JPY | -4.82% |
| 2013 | 64.02 Billion JPY | 516.65% |
| 2012 | 10.38 Billion JPY | -85.19% |
| 2011 | 70.12 Billion JPY | 67.55% |
| 2010 | 41.85 Billion JPY | 119.42% |
| 2009 | -215.49 Billion JPY | -320.66% |
| 2008 | 97.66 Billion JPY | 24.33% |
| 2007 | 78.55 Billion JPY | -10.43% |
| 2006 | 87.69 Billion JPY | 81.63% |
| 2005 | 48.28 Billion JPY | 11.22% |
| 2004 | 43.41 Billion JPY | 28.26% |
| 2003 | 33.84 Billion JPY | -12.76% |
| 2002 | 38.79 Billion JPY | -8.67% |
| 2001 | 42.47 Billion JPY | -0.79% |
| 2000 | 42.81 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 57.01 Billion JPY | 153.53% |
| 2024 FY | 200.73 Billion JPY | 83.84% |
| 2024 Q3 | 66.55 Billion JPY | 66.42% |
| 2024 Q4 | 37.16 Billion JPY | -44.16% |
| 2024 Q2 | 39.99 Billion JPY | -29.85% |
| 2023 Q4 | 22.48 Billion JPY | -20.79% |
| 2023 FY | 109.18 Billion JPY | 63.04% |
| 2023 Q3 | 28.39 Billion JPY | -28.05% |
| 2023 Q2 | 39.45 Billion JPY | 109.31% |
| 2023 Q1 | 18.85 Billion JPY | 168.94% |
| 2022 Q2 | 27.24 Billion JPY | -22.64% |
| 2022 Q1 | 35.22 Billion JPY | 23071.05% |
| 2022 Q4 | -27.34 Billion JPY | -185.85% |
| 2022 FY | 66.97 Billion JPY | -11.83% |
| 2022 Q3 | 31.85 Billion JPY | 16.91% |
| 2021 Q1 | 31.85 Billion JPY | 711.81% |
| 2021 Q2 | 19.8 Billion JPY | -37.82% |
| 2021 Q3 | 24.13 Billion JPY | 21.86% |
| 2021 Q4 | 152 Million JPY | -99.37% |
| 2021 FY | 75.95 Billion JPY | -41.15% |
| 2020 Q3 | 69.85 Billion JPY | 231.41% |
| 2020 Q2 | 21.07 Billion JPY | -51.37% |
| 2020 Q1 | 43.34 Billion JPY | 196.69% |
| 2020 FY | 129.07 Billion JPY | 38.18% |
| 2020 Q4 | -5.2 Billion JPY | -107.45% |
| 2019 Q4 | 14.61 Billion JPY | -58.0% |
| 2019 Q3 | 34.78 Billion JPY | 73.37% |
| 2019 Q2 | 20.06 Billion JPY | -16.23% |
| 2019 FY | 93.4 Billion JPY | 54.95% |
| 2019 Q1 | 23.95 Billion JPY | 294.41% |
| 2018 Q2 | 5.12 Billion JPY | -82.42% |
| 2018 Q4 | -12.32 Billion JPY | -132.15% |
| 2018 Q3 | 38.32 Billion JPY | 647.79% |
| 2018 FY | 60.28 Billion JPY | 12.75% |
| 2018 Q1 | 29.15 Billion JPY | 183.98% |
| 2017 Q4 | -34.71 Billion JPY | -188.57% |
| 2017 Q3 | 39.19 Billion JPY | 113.18% |
| 2017 Q2 | 18.38 Billion JPY | -39.92% |
| 2017 Q1 | 30.6 Billion JPY | 207.58% |
| 2017 FY | 53.46 Billion JPY | -35.02% |
| 2016 Q1 | 34.93 Billion JPY | -84.11% |
| 2016 Q4 | -28.44 Billion JPY | -171.06% |
| 2016 FY | 82.28 Billion JPY | -74.46% |
| 2016 Q3 | 40.03 Billion JPY | 11.93% |
| 2016 Q2 | 35.76 Billion JPY | 2.38% |
| 2015 FY | 322.11 Billion JPY | 428.56% |
| 2015 Q2 | 30.33 Billion JPY | 51.8% |
| 2015 Q3 | 51.9 Billion JPY | 71.09% |
| 2015 Q4 | 219.88 Billion JPY | 323.62% |
| 2015 Q1 | 19.98 Billion JPY | 243.2% |
| 2014 Q3 | 37.95 Billion JPY | 105.68% |
| 2014 Q1 | 15.02 Billion JPY | -0.64% |
| 2014 FY | 60.94 Billion JPY | -4.82% |
| 2014 Q4 | -13.95 Billion JPY | -136.77% |
| 2014 Q2 | 18.45 Billion JPY | 22.83% |
| 2013 Q2 | 3.95 Billion JPY | -80.64% |
| 2013 Q4 | 15.12 Billion JPY | -44.29% |
| 2013 FY | 64.02 Billion JPY | 516.65% |
| 2013 Q1 | 20.4 Billion JPY | 385.04% |
| 2013 Q3 | 27.14 Billion JPY | 587.19% |
| 2012 FY | 10.38 Billion JPY | -85.19% |
| 2012 Q1 | 25.3 Billion JPY | 365.24% |
| 2012 Q2 | 11.73 Billion JPY | -53.63% |
| 2012 Q3 | -19.5 Billion JPY | -266.18% |
| 2012 Q4 | -7.15 Billion JPY | 63.29% |
| 2011 Q3 | 27.5 Billion JPY | 44.17% |
| 2011 FY | 70.12 Billion JPY | 67.55% |
| 2011 Q4 | -9.54 Billion JPY | -134.69% |
| 2011 Q2 | 19.08 Billion JPY | -42.31% |
| 2011 Q1 | 33.07 Billion JPY | 1168.14% |
| 2010 Q2 | 25.13 Billion JPY | 490.29% |
| 2010 Q3 | 20.55 Billion JPY | -18.22% |
| 2010 Q4 | 2.6 Billion JPY | -87.31% |
| 2010 FY | 41.85 Billion JPY | 119.42% |
| 2010 Q1 | -6.43 Billion JPY | -107.82% |
| 2009 Q2 | 8.89 Billion JPY | 0.0% |
| 2009 Q3 | -331.8 Billion JPY | -3831.87% |
| 2009 Q4 | 82.33 Billion JPY | 124.81% |
| 2009 FY | -215.49 Billion JPY | -320.66% |
| 2008 FY | 97.66 Billion JPY | 24.33% |
| 2007 FY | 78.55 Billion JPY | -10.43% |
| 2006 FY | 87.69 Billion JPY | 81.63% |
| 2005 FY | 48.28 Billion JPY | 11.22% |
| 2004 FY | 43.41 Billion JPY | 28.26% |
| 2003 FY | 33.84 Billion JPY | -12.76% |
| 2002 FY | 38.79 Billion JPY | -8.67% |
| 2001 FY | 42.47 Billion JPY | -0.79% |
| 2000 FY | 42.81 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AstraZeneca PLC | 5.95 Billion USD | -3270.798% |
| Bristol-Myers Squibb Company PFD CONV 2 | 8.02 Billion USD | -2401.321% |
| CSPC Pharmaceutical Group Limited | 830.91 Million USD | -24057.789% |
| Clarus Therapeutics Holdings, Inc. | -56.51 Million USD | 355300.665% |
| Novartis AG | 14.85 Billion USD | -1251.724% |
| PT Kalbe Farma Tbk. | 179.7 Million USD | -111599.95% |